---
stable_id: R-HSA-9665000
display_name: Phosphorylated heterodimers of ERBB2 KD mutants and EGFR bind GRB2:SOS1
species: Homo sapiens
summary: The following EGFR-binding ERBB2 KD mutants that were shown to activate RAS/RAF/MAPK
  signaling, evidenced by activating phosphorylation of ERKs (MAPK1 and MAPK3), are
  assumed to, like the wild type ERBB2:EGFR heterodimer, directly bind to the GRB2:SOS1
  complex:<br><br>ERBB2 L755S (Trowe et al. 2008, Kancha et al. 2011, Bose et al.
  2013, Cocco et al. 2018);<br>ERBB2 L755P (Kancha et al. 2011);<br>ERBB2 I767M (Ng
  et al. 2015; binding to EGFR indirectly demonstrated by Bose et al. 2013);<br>ERBB2
  D769H (Bose et al. 2013);<br>ERBB2 V777L (Kancha et al. 2011, Bose et al. 2013);<br>ERBB2
  G778_P780dup (Suzawa et al. 2016);<br>ERBB2 T798M (Kancha et al. 2011, Rexer et
  al. 2013);<br>ERBB2 T798I (Hanker et al. 2017);<br>ERBB2 V842I (Bose et al. 2013);<br>ERBB2
  T862A (Kancha et al. 2011);<br>ERBB2 H878Y (Kancha et al. 2011, Hu, Hu et al. 2015,
  Hu, Wan et al. 2015);<br>ERBB2 R896C (Bose et al. 2013);<br>ERBB2 L755_T759del (Bose
  et al. 2013);<br>ERBB2 Y772_A775dup (Wang et al. 2006);<br><br>Activation of RAS/RAF/MAPK
  signaling downstream of the following ERBB2 KD cancer mutants has not been studied
  and they are annotated as candidates:<br><br>ERBB2 L755M<br>ERBB2 L755W<br>ERBB2
  D769Y<br>ERBB2 D769N<br>ERBB2 V777M<br>ERBB2 V777E<br>ERBB2 T733I<br>ERBB2 V842E<br>ERBB2
  H878R<br>ERBB2 R896H
---

# Phosphorylated heterodimers of ERBB2 KD mutants and EGFR bind GRB2:SOS1
**Reactome ID:** [R-HSA-9665000](https://reactome.org/content/detail/R-HSA-9665000)
**Species:** Homo sapiens

## Summary

The following EGFR-binding ERBB2 KD mutants that were shown to activate RAS/RAF/MAPK signaling, evidenced by activating phosphorylation of ERKs (MAPK1 and MAPK3), are assumed to, like the wild type ERBB2:EGFR heterodimer, directly bind to the GRB2:SOS1 complex:<br><br>ERBB2 L755S (Trowe et al. 2008, Kancha et al. 2011, Bose et al. 2013, Cocco et al. 2018);<br>ERBB2 L755P (Kancha et al. 2011);<br>ERBB2 I767M (Ng et al. 2015; binding to EGFR indirectly demonstrated by Bose et al. 2013);<br>ERBB2 D769H (Bose et al. 2013);<br>ERBB2 V777L (Kancha et al. 2011, Bose et al. 2013);<br>ERBB2 G778_P780dup (Suzawa et al. 2016);<br>ERBB2 T798M (Kancha et al. 2011, Rexer et al. 2013);<br>ERBB2 T798I (Hanker et al. 2017);<br>ERBB2 V842I (Bose et al. 2013);<br>ERBB2 T862A (Kancha et al. 2011);<br>ERBB2 H878Y (Kancha et al. 2011, Hu, Hu et al. 2015, Hu, Wan et al. 2015);<br>ERBB2 R896C (Bose et al. 2013);<br>ERBB2 L755_T759del (Bose et al. 2013);<br>ERBB2 Y772_A775dup (Wang et al. 2006);<br><br>Activation of RAS/RAF/MAPK signaling downstream of the following ERBB2 KD cancer mutants has not been studied and they are annotated as candidates:<br><br>ERBB2 L755M<br>ERBB2 L755W<br>ERBB2 D769Y<br>ERBB2 D769N<br>ERBB2 V777M<br>ERBB2 V777E<br>ERBB2 T733I<br>ERBB2 V842E<br>ERBB2 H878R<br>ERBB2 R896H
